| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0.2B | $0.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.2B | $0.2B | $-0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $0.99 | $1.37 | $1.80 | $-1.26 | $0.26 | $0.27 | $0.56 | $0.58 |
| EPS (Diluted) | $0.99 | $1.37 | $1.63 | $-1.26 | $0.26 | $0.27 | $0.55 | $0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.3B | $14.4B | $13.1B | $13.9B | $13.8B | $11.5B | $11.8B | $7.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.3B | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $19.5B | $12.5B | $11.2B | $12.0B | $11.4B | $9.2B | $9.3B | $6.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.9B | $1.9B | $2.0B | $2.0B | $2.4B | $2.3B | $2.5B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-7.2B | $-2.7B | $1.3B | $1.8B | $-2.8B | $0.7B | $-3.0B | $-0.6B |
| Investing Cash Flow | $0.4B | $1.4B | $-0.0B | $-1.9B | $1.1B | $-0.0B | $-0.7B | $-1.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $6.7B | $1.4B | $-1.1B | $0.1B | $1.7B | $-0.7B | $3.7B | $2.0B |